Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacogenomics: from bedside to clinical practice.

Sharon Marsh1, Howard L McLeod

  • 1Division of Oncology, Washington University School of Medicine, St Louis, MO 63110, USA.

Human Molecular Genetics
|May 3, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrating Somatic and Germline Pharmacogenomics for Therapeutic Decisions in Precision Oncology.

JCO precision oncology·2026
Same author

Propranolol metabolite and enantiomers affect colorectal cancer development by inhibiting MAPK pathway and downregulating PD-1 expression.

International immunopharmacology·2025
Same author

A two-stage genome-wide association study to identify novel genetic loci associated with irAEs in lung cancer patients receiving PD-1/PD-L1 inhibitors.

Cancer letters·2025
Same author

Advancing the science of genomic learning healthcare systems.

Learning health systems·2025
Same author

Causal effects of immune cells on the efficacy and adverse drug reactions of platinum drugs.

Acta biochimica et biophysica Sinica·2025
Same author

Pharmacogenomics in Oncology-Running Out of Excuses for Slow Adoption.

JAMA network open·2024

Pharmacogenomics research is advancing rapidly, with discoveries in genetic markers and FDA-approved tests paving the way for personalized medicine. These advances are crucial steps toward integrating pharmacogenomics into routine clinical practice.

Area of Science:

  • Pharmacogenomics
  • Genetics
  • Clinical Pharmacology

Background:

  • The Human Genome Project and International HapMap projects have generated extensive genetic data.
  • Advances in identifying clinically predictive genotypes, haplotypes, and somatic mutations are notable.
  • The integration of pharmacogenomics into clinical practice is an emerging area.

Purpose of the Study:

  • To review recent advances in pharmacogenomics research.
  • To highlight key discoveries and their clinical implications.
  • To discuss the progression towards integrating pharmacogenomics into healthcare.

Main Methods:

  • Literature review of recent pharmacogenomics research.
  • Identification of significant genetic discoveries (genotypes, haplotypes, mutations).

Related Experiment Videos

  • Analysis of FDA-approved pharmacogenetic tests and clinical trials.

    • Main Results:

    • Discovery of clinically predictive genotypes like UGT1A1*28 and TYMS TSER.
    • Identification of haplotypes such as VKORC1 Haplotype A.
    • Development of FDA-approved pharmacogenetic tests and genotype-guided cancer therapy trials.

    Conclusions:

    • Recent pharmacogenomics advances are foundational for personalized medicine.
    • The discovery of genetic markers and development of tests are key steps.
    • Pharmacogenomics integration into clinical practice is progressing, with potential to optimize drug therapy and cancer treatment.